May 17, 2013: Dr. Janet Rowley Received Albany Medical Center Prize in Medicine and Biomedical Research
On May 17, 2013, American geneticist Janet Rowley was awarded the Albany Medical Center Prize in Medicine and Biomedical Research which was an important indicator of being regarded for the Nobel Prize. Rowley’s award-winning study shown that chronic myeloid leukemia cells have abnormal recombination on it chromosome 22, which in turn produces Bcr-Abl mutant kinases. This study was the foundation of developing the first drug (Imatinib) for targeted therapy in the world.
Image Source
https://www.timesunion.com/local/article/Lowering-the-cost-of-saving-lives-4527098.php#photo-4645736
LATEST
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02